KEYCORP

KeyCorp’s new shelf registration lets the bank issue stocks, warrants, and more instantly—boosting capital‑raising flexibility while ensuring SEC and FINRA compliance. The filing, paired with a director’s recent share sale, showcases transparency an…

KeyCorp’s latest UK REIT stake reveals a disciplined, 3 % exposure to LondonMetric and Schroder, balancing hedging options with low‑impact trades.

KeyCorp’s latest equity and derivative moves reveal a risky focus on Advanced Medical Solutions and hidden exposure—why regulators must demand clearer risk disclosure.

KeyCorp’s sale of its Playstack stake will free $720M, boost cash, cut debt, and sharpen focus on telecom infrastructure—transforming risk into higher‑margin, platform‑driven growth.

KeyCorp’s latest quarter shows steady earnings, solid asset quality, and disciplined growth, highlighting its conservative strategy and resilient financial health.

KeyCorp’s 2026 results reveal resilient growth, a Rajkot plant expansion, and precision‑tooling acquisitions that boost margin recovery and ESG alignment—ideal for long‑term investors.

KeyCorp’s latest trading filings reveal routine share trades and limited derivatives, but hidden conflicts and governance gaps raise investor concerns about transparency and impact.

KeyCorp’s latest Takeover Code filings reveal routine share and equity‑swap activity, with no major capital or market impact—clear transparency for investors.

KeyCorp reports a 3.2 % revenue uptick driven by commercial banking growth, strong fee‑income mix, and a 12 % rise in digital transactions, signaling robust profitability and a resilient capital base.

KeyCorp’s Rule 8.5 filings reveal transparent trading activity, guiding investors on volatility, derivative exposure, and potential takeover cues.